Sort
64,565 grants matching “drug discovery”
Development of a Long-acting Enzyme Therapy for Treatment of Cocaine Abuse
$4,721,164Chang-Guo Zhan · University Of Kentucky · U01 · FY2022 · DA
MEB-1170: A New Chemical Entity for the Treatment of Opioid Use Disorder
$4,710,576Lawrence C Kuo · Mebias Discovery, Inc. · UG3 · FY2025 · DA
Resilience/Resistance to Alzheimer's Disease in Centenarians and Offspring (RADCO)
$4,696,857Thomas T Perls · Boston University Medical Campus · U19 · FY2024 · AG
Production of Targeted Null Mutations for 10,000 Genes in C57BL/6 ES Cells
$4,689,520David Manuel Valenzuela · Regeneron Pharmaceuticals, Inc. · U01 · FY2009 · HG
DCTD Screening Technologies
$4,669,431David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2014 · CA
The RCMI Center for Cancer and Health Disparities Research
$4,656,808Guangdi Wang · Xavier University Of Louisiana · U54 · FY2025 · MD
UniProt: A centralized protein sequence and function resource
$4,650,000Alex Bateman · European Molecular Biology Laboratory · U41 · FY2014 · HG
Topographic, cell type and molecular pathway characterization ofAlzheimer's disease using single cell transcriptomics and epigenomics
$4,638,911Ed Lein · Allen Institute · U19 · FY2024 · AG
Developing small molecules to engage an analgesic GPCR in pain unpleasantness neural circuits
$4,637,933Gregory Scherrer · Univ Of North Carolina Chapel Hill · U19 · FY2024 · NS
Silence ALS: A Platform for the Discovery and Development of Antisense Therapeutics for Patients with Ultra-Rare Forms of ALS
$4,636,637Neil Alan Shneider · Columbia University Health Sciences · U01 · FY2025 · NS
Resilience/Resistance to Alzheimer's Disease in Centenarians and Offspring (RADCO)
$4,630,951Thomas T Perls · Boston University Medical Campus · U19 · FY2025 · AG
Whole Genome Sequencing in Ethnically Diverse Cohorts for the ADSP Follow-Up Study (FUS)
$4,626,374Margaret A Pericak-Vance · University Of Miami School Of Medicine · U01 · FY2021 · AG
UAB Center for AIDS Research
$4,615,209Michael S. Saag · University Of Alabama At Birmingham · P30 · FY2016 · AI
Production of Targeted Null Mutations for 10,000 Genes in C57BL/6 ES Cells
$4,614,400David Manuel Valenzuela · Regeneron Pharmaceuticals, Inc. · U01 · FY2007 · HG
In Vitro Evaluation and Characterization of Novel Lead Therapeutic Candidates for Encephalitic Alphavirus Treatment
$4,612,067Donghoon Chung · University Of Tennessee Health Sci Ctr · U19 · FY2022 · AI
Genome-Wide Association Study of Nonsynonymous SNPs in Colon Cancer
$4,609,171Ulrike Peters · Fred Hutchinson Cancer Research Center · R01 · FY2009 · CA
Screening core
$4,602,398Michelle Arkin · University Of California, San Francisco · U19 · FY2022 · AI
Northwestern University Clinical and Translational Science Institute (NUCATS)
$4,602,173Donald M Lloyd-Jones · Northwestern University At Chicago · UL1 · FY2017 · TR
Collaboratory of AIDS Researchers for Eradication (CARE)
$4,592,950David M. Margolis · Univ Of North Carolina Chapel Hill · UM1 · FY2020 · AI
Collaboratory of AIDS Researchers for Eradication (CARE)
$4,592,950David M. Margolis · Univ Of North Carolina Chapel Hill · UM1 · FY2017 · AI
Collaboratory of AIDS Researchers for Eradication (CARE)
$4,592,950David M. Margolis · Univ Of North Carolina Chapel Hill · UM1 · FY2016 · AI
Building and Operating Chemical Factories: Comparative Studies of Biochemical Pathways for Specialized Metabolites in the Solanum
$4,586,618Robert L Last · Michigan State University · · FY2011 · BIO
Penn Center for AIDS Research
$4,562,625Ronald G Collman · University Of Pennsylvania · P30 · FY2022 · AI
Non-invasive Neuromodulation Unit (NNU)
$4,562,464Sarah Lisanby · National Institute Of Mental Health · ZIA · FY2021 · MH
UAB Center for Clinical and Translational Science (CCTS) UL1
$4,554,418Robert P Kimberly · University Of Alabama At Birmingham · UL1 · FY2013 · TR